Diffusion Pharmaceuticals' Convertible Note - III Round

Diffusion Pharmaceuticals raised a round of funding on September 04, 2014.

Diffusion Pharmaceuticals is a clinical-stage company developing drugs which target the unmet medical needs characterized by oxygen deprivation (hypoxia) at the cellular level. These small molecules w…

Articles about Diffusion Pharmaceuticals' Convertible Note - III Round: